COMMENTARY: The FDA’s Reclassification Of Transvaginal Mesh And Its Implications On Pending Litigation

Mealey's (February 12, 2016, 10:05 AM EST) -- By Jayne Conroy

[Editor’s Note: Jayne Conroy is a named shareholder of Simmons Hanly Conroy and a member of the Plaintiffs’ Steering Committee for the In re Pelvic Repair System Products Liability Litigation, MDL 2325, 2326 & 2327. She has served as a member of Plaintiffs’ Steering or Executive Committees in nearly a dozen multidistrict pharmaceutical litigations. Her practice currently focuses on various complex civil cases, including a wide variety of products liability matters, pending litigation against Volkswagen on behalf of several thousand plaintiffs who were...
To view the full article, register now.